Literature DB >> 26939385

Intrathecal Opioid-Induced Hypothermia Following Subarachnoid Block With Morphine Injection for Elective Cesarean Delivery: A Case Report.

John Mach, Teresa Van Havel, John Gadwood, M Andrew Biegner.   

Abstract

Opioids have been administered intrathecally with subarachnoid block for postoperative pain relief in parturients undergoing elective cesarean deliveries. This case report presents the uncommon occurrence of intrathecal opioid-induced hypothermia in the latent phase of recovery following elective cesarean delivery. There are few case reports on the occurrence of latent-phase postanesthesia care hypothermia in patients receiving subarachnoid block with morphine sulfate injection (Duramorph). Hypothermia can occur postoperatively for many reasons and can be life-threatening. In this case, hypothermia developed and progressed throughout the postoperative period. The causes of hypothermia were evaluated and treated without success initially. Thyroid dysfunction and alternative differential diagnoses were ruled out. Further assessment determined that the morphine injection might have been a contributing factor. Naloxone at 40-μg increments was administered intravenously and corrected the hypothermia. Awareness of hypothermia postoperatively with associated morphine administration through subarachnoid block must be ruled out in cases of progressing hypothermia.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26939385

Source DB:  PubMed          Journal:  AANA J        ISSN: 0094-6354


  2 in total

1.  Postpartum Maternal Hypothermia in an Adolescent Patient Following Spontaneous Vaginal Delivery.

Authors:  Kara Weishaar; Erin Bailey; Hana El Ado Mikdachi; Jessica E Murphy
Journal:  Cureus       Date:  2022-08-18

2.  Persistent Hypothermia and Excessive Sweating Following Intrathecal Morphine Administration in a Teenage Boy: A Case Report.

Authors:  Sara Ferraz; Telma Caria; Aline Vaz Da Silva; Maria Jose Candeias; Teresa Cenicante
Journal:  Anesth Pain Med       Date:  2018-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.